Featured
Which pharma nets $1.4M... every 20 minutes?
An analysis of the world's top 200 companies reveals three pharmas are raking in seven-figures in net profit in under half an hour. Find out how fast your company makes US$1M
Industry & Companies
The pharma influencer adding emotion to data
From a standing ovation in Chicago to your screen in less than a day, a novel way to learn about the exciting conference sessions that are relevant to Australia
Jobs & Workplace
Long-timers jump to new companies
After more than a decade with the same company, these executives are moving on. Find out the latest appointments across industry
Leadership & People
How Dolly quietly reshaped pharma
Dolly Parton released 25 hit singles, but it was her philanthropy efforts that made her a superstar in pharma, helping launch a first-of-its kind drug that became a household name around the world
Regulatory & Reimbursement
First treatment funded through new pathway
Rare disease patient has received treatment otherwise unavailable in Australia thanks to a new Innovative Therapies Pathway - and it only took six weeks
Featured
Salary rift emerges across pharma
There is a growing divide in Australian pharma between what companies want to pay and what workers are willing to accept with the fallout being felt across industry
Featured
Who will survive the next pharma downsize?
A brutal downsizing is coming to pharma with a broad range of roles simply ceasing to exist. Australian experts have revealed the skills and capabilities needed to survive
Industry & Companies
Aussie jobs to go after trial failure
Dose-limiting toxicities has scuppered an otherwise promising cancer program, seeing a local company cut jobs and scope out possible ways to remain a going concern
Industry & Companies
Roche muscles up with $3.2B weight loss play
The company has put money down for a potential first-in-class rival in the lucrative obesity space for an asset that allows patients to shed kilos but preserves muscle
Regulatory & Reimbursement
EU tick paves way for bumper payday
Aussie company notches another success with the EMA giving marketing approval for its flagship product treating a rare neurological disease
Jobs
Regulatory & Reimbursement
PBAC July meeting winners and losers
Almost three-quarters of the new PBS listing submissions considered by PBAC in July won green light, but some big names drugs were delivered a blow
Regulatory & Reimbursement
PBAC says no to higher price for blockbuster
Company 'disappointed' after the PBAC knocked back a revised submission for this much-needed biologic due to price
Latest
AI tool builds synthetic patients and HCPs for pharma
Companies will be able to test messaging and materials in days, rather than months, with responses based on real clinician-patient conversations
Regulatory & Reimbursement
Pfizer touts Australian results
Results of a year-long study conducted in Australia has been published in JAMA Pediatrics reinforcing the effectiveness of this maternal immunisation
- Other News Gene therapy may prevent heart transplants in kids
- Regulatory & Reimbursement New antibiotic arrives in Australia
- Other News Pharma PR campaigns shortlisted for awards
- Leadership & People GSK prize marks revolution in respiratory care
- Regulation & Legal TGA dishes five-figure prescription drug fine
- Regulation & Legal Black market booms for future blockbuster
- Other News Who's got a new job at an old company?
- Industry & Companies 'Rare' uptick in pharma's corporate reputation
- Industry & Companies Aussie company on track to bank its first billion
- Industry & Companies Whose share price almost tripled overnight?
